ADPT vs JNJ: Which Stock is Better?
Side-by-side comparison of Adaptive Biotechnologies Corp and Johnson & Johnson in 2026
ADPT
Adaptive Biotechnologies Corp
$17.87
JNJ
Johnson & Johnson
$218.21
Key Metrics Comparison
| Metric | ADPT | JNJ | Winner |
|---|---|---|---|
| Market Cap | $2.73B | $525.73B | JNJ |
| P/E Ratio | N/A | 21.10 | JNJ |
| EPS (TTM) | $N/A | $10.34 | JNJ |
| Revenue Growth | 1.0% | 0.1% | ADPT |
| Gross Margin | 65.1% | 68.4% | JNJ |
Analyze ADPT
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADPT or JNJ a better investment?
Comparing ADPT and JNJ: Adaptive Biotechnologies Corp has a market cap of $2.73B while Johnson & Johnson has $525.73B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADPT and JNJ?
ADPT (Adaptive Biotechnologies Corp) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADPT or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ADPT or JNJ?
ADPT has higher revenue growth at 1.0% vs 0.1% for JNJ.
Which company is more profitable: ADPT or JNJ?
Johnson & Johnson (JNJ) has higher gross margins at 68.4% compared to 65.1% for ADPT.
Which is the larger company: ADPT or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $525.73B compared to $2.73B for ADPT.
Should I buy ADPT or JNJ in 2026?
Both ADPT and JNJ have investment merit. ADPT trades at $17.87 while JNJ trades at $218.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADPT and JNJ stock?
Key differences: Market Cap ($2.73B vs $525.73B), P/E Ratio (N/A vs 21.1x), Revenue Growth (1.0% vs 0.1%), Gross Margin (65.1% vs 68.4%).